- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Ltd. (PFIZ)
Pfizer Ltd. stock price, this page displays NSE PFIZ stock exchange data. View the PFIZ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pfizer Ltd. real time stock price chart below.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PFIZ quote. (ISIN: INE182A01018)
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PFIZ quote. (ISIN: INE182A01018)
4,695.00
-9.50(-0.20%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,627.50
4,753.00
52 wk Range
3,701.00
5,993.00
PFIZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,627.504,753.00
52 wk Range
3,701.005,993.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PFIZ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
6,658.33
Upside
+41.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Compare PFIZ to Peers and Sector
Metrics to compare | PFIZ | Peers Peers - average of corresponding metrics from companies closely matching PFIZ: MANKIND, ALKEM, AJANTPHARM, EMCURE, CIPLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPFIZPeersSector |
|---|---|---|---|---|
P/E Ratio | 25.2x | 28.0x | −0.5x | |
PEG Ratio | 0.65 | 1.57 | 0.00 | |
Price/Book | 5.6x | 5.6x | 2.6x | |
Price / LTM Sales | 8.7x | 4.3x | 3.2x | |
Upside (Analyst Target) | 35.6% | 8.3% | 49.3% | |
Fair Value Upside | Unlock | 6.7% | 6.3% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6,658.33
(+41.82% Upside)
Earnings
Latest Release
Feb 09, 2026
EPS / Forecast
40.40 / 37.50
Revenue / Forecast
6.45B / 5.89B
FAQ
What Is the Pfizer Ltd (PFIZ) Stock Price Today?
The Pfizer Ltd stock price today is 4,695.00.
What Stock Exchange Does Pfizer Ltd Trade On?
Pfizer Ltd is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Pfizer Ltd?
The stock symbol for Pfizer Ltd is "PFIZ."
Does Pfizer Ltd Pay Dividends? What’s The Current Dividend Yield?
The Pfizer Ltd dividend yield is 0.75%.
What Is the Pfizer Ltd Market Cap?
As of today, Pfizer Ltd market cap is 214.79B.
What Is Pfizer Ltd's Earnings Per Share (TTM)?
The Pfizer Ltd EPS (TTM) is 186.59.
When Is the Next Pfizer Ltd Earnings Date?
Pfizer Ltd will release its next earnings report on 03-06-2026.
From a Technical Analysis Perspective, Is PFIZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Pfizer Ltd Stock Split?
Pfizer Ltd has split 0 times.
How Many Employees Does Pfizer Ltd Have?
Pfizer Ltd has 1598 employees.
What is the current trading status of Pfizer Ltd (PFIZ)?
As of 12-03-2026, Pfizer Ltd (PFIZ) is trading at a price of 4,695.00, with a previous close of 4,695.00. The stock has fluctuated within a day range of 4,627.50 to 4,753.00, while its 52-week range spans from 3,701.00 to 5,993.00.
What Is Pfizer Ltd (PFIZ) Price Target According to Analysts?
The average 12-month price target for Pfizer Ltd is INR6,658.33, with a high estimate of INR7500 and a low estimate of INR6100. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +41.82% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.